Broncus Medical, Inc., talks of the publication of results from the VAPORIZE study in the current issue of Respiration. The paper’s authors conclude that, … continue reading “Positives for Broncus BTVA System”
Eschmann Technologies has launched a revolutionary air disinfection system, developed by Novaerus to help protect dentists against the spread of airborne … continue reading “Air Disinfection Protects Dental Practices Against COVID-19”
The U.S. FDA has granted Emergency Use Authorization to Ortho Clinical Diagnostics’ total antibody assay for COVID-19 – the VITROS® … continue reading “FDA Emergency Use Authorization for Ortho’s COVID-19 Total Antibody Test”
Unlike simple face masks or surgical masks, respiratory masks protect against aqueous and oily aerosols, smoke and fine dust. Clinova … continue reading “Flu Respirator or Surgical Face Mask?”
Non-invasive diagnostic sleep apnea device expert Itamar Medical Ltd. has announced that Blue Shield of California (BSC) and the Blue … continue reading “Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include Itamar WatchPAT™ in Their Policies”
The RejuvenAir® System has been designated as a Breakthrough Device by the U.S. FDA. The company has also received unconditional IDE approval to initiate a pivotal clinical study.
Medtronic says Microstream™ Capnography study shows a greater than 40% incidence of opioid induced respiratory compromise
RejuvenAir® feasibility study demonstrate strong safety profile and clinically meaningful improvement on Quality of Life measures at 6-month follow-up in Chronic Bronchitis patients.
Studies presented at the European Society of Thoracic Surgeons meeting examine the impact of innovation on both patient outcomes and hospital costs
Evidence-based guidelines based on a large-scale sleep apnea study demonstrate WatchPAT’s efficiency and accuracy
System safe, accurate and effective in bronchoscopically navigating and accessing tumors anywhere in the lung
All primary and secondary endpoints met across multiple measures of breathing and quality of life, one year after treatment
Real-world assessment favours powered staplers over manual, with halved rate of hemostasis complications
Already available around the world, Pulmonx hopes to get FDA nod for U.S. patients
Leading UK pulmonologist interprets new guidance to mean that all eligible patients should be referred to specialists for consideration for endobronchial valve treatment.
Portable analyzer helps patients manage their asthma by measuring nitric oxide (NO) in their exhaled breath, a biomarker foreshadowing airway obstruction